Microbiologically documented infections following peripheral blood stem cell transplantation: Single center experience

Turkish Journal of Haematology

Volumn 22, Issue 3, 2005, Pages 133-145

  Altuntaş, Fevzi ^a   Yildiz, Orhan ^a   Eser, Bülent ^a   Alp, Emine ^a   Sari, Ismail ^a   Çetin, Mustafa ^a   Sümerkan, Bülent ^a   Ünal, Ali ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Bacterial; Fungal; Infection; Peripheral blood stem cell; Transplantation

Indexed keywords

ACICLOVIR; AMIKACIN; AMINOGLYCOSIDE; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMIPENEM; METHOTREXATE; METHYLPREDNISOLONE; METICILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATION; CATHETER INFECTION; CLINICAL OBSERVATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FEVER; FUNGUS; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE FACILITY; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NEUTROPENIA; PATHOGENESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SOLID TUMOR; TREATMENT PLANNING;

EID: 28944436358     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gratwohl A, Hermans J, Baldomero H. Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation. Bone Marrow Trans 1996;17:137-48.
2. Donowitz GR. Fever in the compromised host. Infect Dis Clin N Am 1996;10:129-48.
3. Pizzo PA. Empirical therapy and prevention of infection in the immuno-compromised host. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. New York: Churchill-Livingstone; 1995:2686.
4. Watson JG. Problems of infection after bone marrow transplantation. J Clin Pathol 1983;36:683-92.
5. Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986;81:27-38.
6. Paulin T, Ringden O, Nilsson B, Lonnqvist B, Gahrton G. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987;43:393-8.
7. Vose JM, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992;69:784-9.
8. Nosanchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D. Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Trans 1996;18:355-9.
9. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Trans 1996;18:265-71.
10. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Trans 1997;19: 143-7.
11. Kirk JL, Greenfield RA, Slease B, Ebstein RB. Analysis of early infectious complications after autologous bone marrow transplantation. Cancer 1988; 62:2445-50.
12. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991;114:332-3.
13. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15: 197-210.
14. Greene JN. Catheter-related complications of cancer therapy. Infect Dis Clin North Am 1996;10:255-95.
15. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an International Consensus. Clin Infect Dis 2002;34:7-14.
16. Akan H, Koç H, Arslan O, et al. Febrile neutropenia in a bone marrow transplantation unit. International Journal of Antimicrobial Agents 1997;8:127-30.
17. Celebi H, Akan H, Akcaglayan E, et al. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Trans 2000;26:211-4.
18. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994;18:273-81.
19. Ketterer N, Espinouse D, Chomarat M, et al. Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med 1999;106:191-7.
20. Engels EA, Ellis CA, Supran SE, et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999;28:256-66.
21. Salazar R, Sola C, Maroto P, et al. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Trans 1999;23: 27-33.
22. Bodey G. Antibiotics in patients with neutropenia. Arch Int Med 1984;144:1845-51.
23. Klastersky J. Empiricial antibiotic therapy in neutropenic cancer patients. Eur J Cancer 1993;29A (Suppl 1):6-10.
24. Winston DJ. Prophylaxis and treatment of infection in the bone marrow transplant recipients. Curr Clin Top Infect Dis 1993;13:293-321.
25. Van Kraaij MG, Verdonck LF, Rozenberg-Arska M, Dekker AW. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence. Bone Marrow Transplant 2002;30:303-9.
26. Kruger W, Russmann B, Kroger N, et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation a 7 year single centre investigation of 409 cases. Bone Marrow Transplant 1999;23:589-97.
27. Klastersky J, Zinner SH, Calandra T, et al. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 1988;24(Suppl 1):35-45.
28. Villablanca JG, Steiner M, Kersey J, et al. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Trans 1990;6:387-93.
29. Valteau D, Hartmann O, Brugieres L, et al. Streptococcal septicemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Trans 1991;7:415-9.
30. Ku SC, Tang JL, Hsueh PR, Luh KT, Yu CJ, Yang PC. Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:1293-7.
31. Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-Albos A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18:809-12.
32. Ip MS, Yuen KY, Woo PC, et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998;158:1173-7.
33. Aljurf M, Gyger M, Alrajhi A, et al. Mycobacterium tuberculosis infections in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999;24:551-4.
34. De La Camara R, Martino R, Granados E, et al. Tuberculosis after hematopoietic stem cell transplantation; incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000;26:291-8.
35. Oreke CH, Dudley MN. β-lactam/β-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host. J Antimicrob Chemother 1998;41(Suppl D):43-9.
36. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998;41(Suppl D):7-11.
37. Klastersky J. Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 1998;41(Suppl D):13-24.
38. Hiemenz J, Skelton J, Pizzo PA. Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis 1986;5:6-11.
39. Koll BS, Brown AE. Changing patterns of infections in the immunocompromised patient with cancer. Hematol Oncol Clin North Am 1993;7:753-69.
40. Wimperis JZ, Baglin TP, Marcus RE, Warren RE. An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts. Bone Marrow Transplant 1991;8:363-7.
41. Lew MA, Kehoe K, Ritz J, et al. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation 1991;51:630-6.
42. Winston DJ, Ho WG, Bruckner DA, Gale RP, Champlin RE. Ofloxacin versus vancomycin/polymyxin for prevention of infection in granulocytopenic patients. Am J Med 1990;88:36-42.
43. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:1147-201.
44. Aksu G, Ruhi MZ, Akan H, et al. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Trans 2001;27:201-5.
45. Denning DW, Evans EG, Kibbler CC, et al. Guidelines for the investigation of invasive fungal infections in hematological malignancy and solid organ transplantation. Eur J Clin Microbiol Infect Dis 1997;16:424-36.
46. Kruger W, Russmann B, Kroger N, et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation-a 7 year single centre investigation of 409 cases. Bone Marrow Trans 1999;23: 589-97.
47. Goodrich JM, Reed EC, Mori M, et al. Clinical features and analysis of risk factors for invasive Candida infection after marrow transplantation. J Infect Dis 1991;164:731-40.
48. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Trans 1987;2:175-81.
49. Lortholary O, Dupont B. Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev 1997;10:477-504.
50. Verbist L, for the International Study Group. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. Scand J Infect Dis Suppl 1993;91:14-24.
51. McWhinney PH, Kibbler CC, Hamon MD, et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 1993;17:397-404.
52. De Bock R, Middelheim AZ. Febrile neutropenia in allogeneic transplantation. Int J Antimicrob Agents 2000;16:177-80.